How sensing technology advances Organ-on-Chip innovation

The combination of advanced chip technology, biology and artificial intelligence is opening new possibilities for more predictive and personalised drug development. Organ‑on‑Chip (OoC) technology plays an important role in this transformation by recreating aspects of human organ functions on miniature platforms, enabling researchers to study biological responses and evaluate potential treatments in more human‑relevant conditions.

At imec at Holst Centre, researchers are contributing to this progress by developing advanced sensing technologies that enable precise, real‑time monitoring within Organ‑on‑Chip systems. By moving beyond static measurements towards continuous biological monitoring, these technologies generate richer, more reliable datasets that can support advanced analytics and AI. This approach helps improve the predictability of drug development and supports the wider adoption of OoC technologies in research and industry.

Sneha, Portfolio Manager within imec's Life Sciences division, plays a role in connecting technological innovation with the needs of the pharmaceutical and biotechnology industries. Her work focuses on integrating sensors, data and hardware into complex biological models, helping translate advanced research into practical applications. Together, these developments highlight how imec's expertise in nanoelectronics and sensing technologies is contributing to the future of personalised medicine.

Read the original article: How Flanders is reinventing drug research